OGN, Osteoglycin (mimecan) is a class II SLRP with diverse roles in ECM assembly, regulates bone formation along with TGF‐β1/TGF‐β2 to control collagen fibrillogenesis and also has regulatory roles in metabolic health, cancer and diabetes regulating glucose homeostasis. The gene discussed is OGN; the disease is cancer.